Fox Business Flash top headlines are here. Check out what's clicking on FoxBusiness.com.
India’s Biocon Ltd has received regulatory approval for its drug Itolizumab to be used on coronavirus infected patients suffering from moderate to severe respiratory distress, the biopharmaceutical company said in a statement on Saturday.
Continue Reading Below
The drug, which is also used to cure the skin disease psoriasis, was cleared by the Drug Controller General of India (DCGI) for usage in India.
Kiran Mazumdar-Shaw, chair and managing director of Biocon. (Biocon)
BILL GATES CALLS FOR COVID-19 MEDS TO GO TO PEOPLE WHO NEED THEM, NOT ‘HIGHEST BIDDER’
“The randomized control trial indicated that all the patients treated with Itolizumab responded positively and recovered,” said Kiran Mazumdar-Shaw, the firm’s executive chairperson.
The control group which did not receive Itolizumab unfortunately suffered deaths, she said, adding that the “first-in-class” drug will save lives and help reduce the mortality rate in India.
The Biocon research center (Biocon)
GET FOX BUSINESS ON THE GO BY CLICKING HERE
Clinical studies involving the drug are being closely watched as nations look for treatments for the disease that has infected over 820,000 people and killed over 22,000 in India.
India recorded 27,114 coronavirus cases in the last 24 hours. The South Asian country’s coronavirus case tally has made it the nation with the third-biggest outbreak, behind only the United States and Brazil in confirmed infections.
The DGCI earlier this month approved pharmaceutical firm Zydus Cadila to start phase one and phase two human clinical trials of its COVID-19 vaccine. Itolizumab is the second vaccine to gain approval after Hyderabad-based Bharat Biotech’s COVAXIN.
READ MORE ON FOX BUSINESS BY CLICKING HERE
"use" - Google News
July 11, 2020 at 10:18PM
https://ift.tt/2Zjn7eL
India's Biocon secures approval use drug on coronavirus patients - Fox Business
"use" - Google News
https://ift.tt/2P05tHQ
https://ift.tt/2YCP29R
Bagikan Berita Ini
0 Response to "India's Biocon secures approval use drug on coronavirus patients - Fox Business"
Post a Comment